Cellectis SA (CLLS)
1.61
+0.02
(+1.26%)
USD |
NASDAQ |
Dec 20, 16:00
1.58
-0.03
(-1.86%)
After-Hours: 20:00
Cellectis Total Liabilities (Quarterly): 266.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Edap TMS SA | 40.66M |
| DBV Technologies SA | 39.02M |
| Genfit SA | 117.09M |
| Akari Therapeutics PLC | 9.428M |
| Biodexa Pharmaceuticals PLC | 6.628M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 395.88M |
| Shareholders Equity (Quarterly) | 129.42M |
| Debt to Equity Ratio | 0.3579 |
| Current Ratio | 1.777 |
| Net Debt Paydown Yield | -1.21% |